With a master’s degree in health services administration from Arizona State University, Gregory “Greg” Angle serves as the president of HCA’s Mountains Division, a system of health care facilities located throughout Idaho, Utah, and Alaska. Committed to involvement in the healthcare management field outside of his everyday work, Greg Angle maintains membership with the American Hospital Association (AHA), a professional organization that provides support and advocacy for hospitals.
In July 2019, the AHA reported on new guidance from the U.S. Food and Drug Administration (FDA) containing draft provisions for medication labeling for drugs that carry the inherent risk of abuse or addiction/dependence. Currently, many of these drugs carry warnings and usage instructions that are overly complicated. Some of the suggested changes include simplifying complex medical terminology and setting clear definitions for terms such as abuse, addiction, and physical dependence. Additionally, the guidance instructs specific labels for opioid medications that provide instructions on how health care providers can taper down dosage in patients who have become dependent. The eventual goal for this practice would be a dose that helps control pain but doesn’t lend itself to greater use/abuse. The FDA also wants providers to develop visual instructions and information for these patients concerning risks and other important factors.
0 Comments
Leave a Reply. |
Archives
January 2020
Categories
All
|